Research Institute on Population and Social Policies

EN IT
EN IT

Among the indicators used in cancer epidemiology, the one that best represents its impact on society is prevalence, understood as the percentage of people living on a certain date who had previously had a diagnosis of the disease.

The prevalence is estimated starting from the information coming from the Population Cancer Registers, which collect the data relating to the cancer diseases of all the residents of a given territory. The cases preceding the activation of the Cancer Registry, which have not been observed but are still alive, are estimated thanks to the COMPREV software, developed by the National Cancer Institute (USA) in collaboration with researchers from the Research Institute on Population and Social Policies (IRPPS) and the National Institute of Health (ISS).

The objective of the current COMPREV project is, on the one hand, the development of a methodology that can be integrated into the COMPREV software for calculating the prevalence by phases of treatment: initial treatment, monitoring and last year of life and, from 'other, to provide the skills for the restyling and updating of the software.

Silvia Francisci

[sp_easyaccordion id = "12556"]